Publications

Results 697 to 708 of 3848

26 September 2020

Supervised injection facilities and other supervised consumption sites: Effectiveness and value

ICER addresses the US' escalating opioid overdose epidemic and assesses a multi-faceted approach to unifying the health sector in spreading awareness and providing treatment to those seeking help.

25 September 2020

So near yet so far: Why won’t the UK prescribe medical cannabis?

Despite medicinal cannabis products now being legal in the UK, patients still face stiff resistance from their prescribers in gaining access to the treatment they need.

25 September 2020

Exploring hidden narratives in the West African tramadol trade and transport of migrants

Policy Bristol calls to address the illicit tramadol trade's root causes. Underfunded healthcare, migration overflow, and unemployment are the primary concerns; not people with drug dependencies.

24 September 2020

INPUD Annual Report 2018-2019

INPUD's 2018/19 report recaps their successes in advocating for people who use drugs and campaigning for human rights and greater access to health services across the world.

22 September 2020

Representation of adverse childhood experiences is associated with lower public stigma towards people who use drugs: an exploratory experimental study

Sumnall et al.'s research suggests insights into the life histories of people who experience challenges related to their drug use can elicit less stigmatising responses.

22 September 2020

Rights in a pandemic – Lockdowns, rights and lessons from HIV in the early response to COVID-19

UNAIDS offers a pandemic response guide focusing on justice, access to services and participation, while highlighting the impacts public health measures have on the most vulnerable.

11 September 2020

Global Drug Survey COVID-19 special edition: Key findings report

This GDS edition focused on the impact of the pandemic on people's use of drugs, mental health and relationships.

11 September 2020

Estratégia regional para o VIH, tuberculose, hepatite B & C e saúde reprodutiva e sexual e direitos entre as populações-chave na CEDEAO

A CEDEAO reconhece a importância de garantir o acesso aos serviços de redução de danos, removendo as barreiras socio-estruturais, incluindo através da descriminalização.

11 September 2020

ECOWAS regional strategy for HIV, tuberculosis, hepatitis B & C and sexual and reproductive health and rights among key populations

ECOWAS acknowledges the importance of ensuring access to harm reduction services by removing socio-structural barriers, including through decriminalisation.

11 September 2020

“Coming out”: Stigma, reflexivity and the drug researcher’s drug use

Ross et al. discuss dynamics of risk and privilege concerning the lived/living experiences of drug researchers who use drugs.

10 September 2020

‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work

A.Greer et. all highlight peer workers are particularly vulnerable to precarious working conditions, entrenching inequities and imperilling the harm reduction response.

10 September 2020

Recreational cannabis regulation and harm reduction - BERL reports to the New Zealand Ministry of Justice

BERL costs the potential impact of a legal cannabis market in New Zealand / Aotearoa.